Keep hope alive! Porton Pharma Solutions Ltd. Tengyi Plan invites you to continue to pay attention to DMD

From September 6 to 7, 2024, Porton Pharma Solutions Ltd. Tengyi plans to go to Shanghai to participate in the 2024 13th China Rare Disease Summit Forum with four Chongqing DMD (Duchenne Muscular Dystrophy) patient families.

The forum will be held from September 6th to 8th, 2024. This conference is jointly hosted by the Coude Rare Disease Center and Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, with the theme of "Standing side by side on rare roads to build dreams".

During this summit forum, we and our families participated in the "Duchenne Muscular Dystrophy (DMD) Academic Symposium". The conference invited medical experts and biopharmaceutical company representatives who have long been dedicated to the diagnosis, treatment and research of DMD across the country to share the latest domestic and foreign research results and treatment strategies on DMD with families of DMD patients from all over the country through various interactive forms such as theme reports and roundtable forums. 为中国DMD疾病的未来发展方向，为患者带来更多福祉。

通过这次论坛，我们不仅看到了DMD研究领域的快速发展，更看到了社会各界对DMD患者由衷的关爱。 所有的希望都会实现，它将不再是一个梦。

未来，Porton Pharma Solutions Ltd.腾益计划将持续关注 DMD ，让好药更早惠及大众。